SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
GALECTIN THERAPEUTICS INC
(NQSC:GALT Last Sale: 2.93 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (GALT : $2.93)
$167,101 million Market Cap at Market Close, July 1, 2022
Drugs SubIndustry up .00% / Health Industry up .00% Today

Norcross, GA Research Report Earnings Snapshot - Last 03/21/18
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


Galectin Therapeutics is in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Company’s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function.
Historical Charts    Technical Analysis
No Historical Data available for GALT

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common GALT $2.93 $2.93 0 .0 $2.65 $2.95 332,260 $2.65 $2.95 57,031,027
Units GALTU $30.65 $ 0 $28 $34 6,400 $3.25 $20.95 0
Warrants GALTW $6.57 $ 0 $5.82 $8 141,222 $.3105 $6.33 0
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $167,100,909

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex